In this episode, Dr. Sean P. Collins sheds light on castrate-resistant prostate cancer (CRPC). He explains what this type of prostate cancer is, the challenges it presents, and how an innovative treatment option like Pluvicto could be the answer certain patients may be looking for. Dr. Collins dives into how this innovative therapy works and who it may benefit, offering hope to those facing limited treatment options. In breaking down how Pluvicto is administered and potential side effects, he shares a comprehensive picture on this particular avenue in care. For more information visit Tampa General Hospital’s Cancer Institute